Better International ETF: Schwab's SCHF vs. the iShares IEFA

Schwab International Equity ETF (SCHF) returned 29.3% over the year through Aug. 27, 2026, outperforming iShares Core MSCI EAFE ETF (IEFA) at 21.8%, while charging a lower 0.03% expense ratio versus 0.07%. IEFA is substantially larger at $196.0 billion in AUM and holds 2,616 securities versus SCHF's $69.7 billion and 1,494 holdings, providing broader developed-market exposure including international small caps. SCHF's South Korean exposure—particularly Samsung Electronics and SK Hynix—has supported recent performance through AI-memory demand, whereas IEFA excludes South Korea as an emerging market.

Analysis

The meaningful distinction is not the four-basis-point fee gap but the embedded Korea semiconductor factor. SCHF functions as a developed-market allocation plus a concentrated AI-memory exposure through Samsung and SK Hynix, whereas IEFA is a cleaner Japan/Europe financials-industrials allocation. If the AI capex cycle remains supply-constrained, memory pricing and high-bandwidth-memory demand can keep SCHF’s relative performance positive over the next 1-3 quarters; a reversal in memory spot prices would expose the same concentration as a source of downside.

For ASML, both vehicles provide indirect incremental ownership, but ETF switching itself is immaterial relative to ASML’s order-cycle, export-control, and foundry-capex drivers. The more relevant second-order effect is that investor demand for “international diversification” can inadvertently increase semiconductor-beta rather than reduce it when routed through SCHF. Investors seeking geographic diversification while reducing AI concentration should favor IEFA or pair developed-market exposure with a separate, deliberately sized semiconductor allocation.

There is unlikely to be a durable tradable flow catalyst from a retail ETF comparison: both products are already mature, highly liquid core vehicles, and the annual fee differential is too small to outweigh taxable-account frictions or institutional benchmark constraints. The contrarian risk is that the trailing return gap is late-cycle memory beta being mistaken for superior index construction. A 10-15% correction in Korean memory leaders, potentially triggered by weaker hyperscaler capex guidance or falling DRAM/NAND contract prices, would likely compress SCHF’s relative premium quickly over days to months.

SCHW’s economics are only marginally affected by incremental SCHF assets because of the fund’s ultra-low fee rate; the strategic value is client-retention and platform cash balances, not a near-term earnings lever. Treat any asset-flow pickup as a watch item until monthly ETF flow data shows sustained share gains versus iShares, rather than a basis for an SCHW position.

Key Decisions for Investors

• For a 1-3 month AI-memory continuation view, use long SCHF versus IEFA as a relative-value expression; size modestly because the spread is principally Korea semiconductor beta, not a clean manager-selection trade. Exit if Samsung/SK Hynix memory-price indicators weaken materially or major hyperscalers cut capex guidance.
• For international equity exposure with lower AI cyclicality, allocate to IEFA rather than SCHF and separately determine ASML/NVDA exposure; this avoids unintentionally stacking portfolio semiconductor risk.
• Do not initiate a directional SCHW trade on this item. Set an alert for three consecutive months of meaningful SCHF net inflows and evidence of Schwab brokerage share gains; absent that, fee revenue sensitivity is too small to support a catalyst-driven thesis.
• If SCHF materially outperforms IEFA further without corresponding upward revisions to memory earnings estimates, consider taking profits on the SCHF/IEFA spread; risk/reward becomes asymmetric as AI-memory expectations embed a sustained pricing upcycle.